Tarsier Pharma Ltd. (TARX)

Tarsier Pharma will go public soon, but the exact IPO date is still unknown.

IPO Price Range

$8.00 - $10.00

Shares Offered

5,555,555

Deal Size

$50.00M

Tarsier Pharma Financials Overview

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024
Period Ending	Dec '25 Dec 31, 2025	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Operating Income	-2.55	-2.55	-2.4
Net Income	5.07	5.07	2.46

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024
Period Ending	Dec '25 Dec 31, 2025	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Cash & Investments	2	2	1.22
Total Debt	6.62	6.62	3.6
Net Cash (Debt)	-4.62	-4.62	-2.38
Net Cash Growth	-	-	-

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024
Period Ending	Dec '25 Dec 31, 2025	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Operating Cash Flow	-1.32	-1.32	-1.91
Capital Expenditures	-0	-0	-0
Free Cash Flow	-1.32	-1.32	-1.91
Free Cash Flow Growth	-	-	-